Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

What Impact Does an Initial Psycho-oncological Contact Have on People With Cancer?

When diagnosed with cancer, patients or their relatives may, if they wish, on the recommendation of the treatment team and/or in cases of high stress, seek psycho-oncological support. This study investigates whether an initial consultation with a psycho-oncological specialist reduces anxiety and depression, improves quality of life, and whether patients subsequently make greater use of support services. Participants will be randomised, meaning they will be assigned to groups at random to ensure that the results are comparable. In the intervention group, participants will receive a detailed initial consultation with a psycho-oncology specialist and standard treatment. In the control group, participants receive standard treatment. To gather results, questionnaires are administered at regular intervals (at the start, after 3 and 6 months). The study lasts a total of 6 months. The study was developed by patients. It is being conducted simultaneously at several hospitals.

Participants needed: 148
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Lindenhofgruppe AGUpdated: Apr 22, 2026Locations: 5
Eligibility criteria

Patients with an oncological disease diagnosed within the last 3 months with pla... [+4]

Documented severe functional impairment according to the ECOG Performance Status... [+4]

Status: Recruiting

Comparison of Radiographic Fusion Rate and Clinical Outcome of ALIF and XLIF Performed With Either Recombinant Human Bone Morphogenetic Protein-2 or ViviGen®

The aim of this study is to prospectively investigate the potential for bony fusion of ViviGen® bone graft substitute in comparison to rhBMP-2 in monosegmental ALIF procedure L5/S1 and in monosegmental XLIF procedure L4/5

Participants needed: 168
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: Lindenhofgruppe AGUpdated: Jun 8, 2025Locations: 1
Eligibility criteria

Patients must be 18 - 70 years of age [+2]

Patients under 18 years and over 70 years of age [+8]